Construction and Validation of a Novel Immune Checkpoint-Related Model in Clear Cell Renal Cell Carcinoma

BACKGROUND: With the highest mortality and metastasis rate, kidney renal clear cell carcinoma (KIRC) is one of the most common urological malignant tumors and not sensitive to chemotherapy and radiotherapy. Immunotherapy, which proves to be effective and a big progression, such as PD-1/PD-L1 inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, ZhiXiang, Sun, XinXin, Li, Kun, Zhang, YanYan, Zuo, ShiKai, Li, CanCan, Wan, Shi, Huang, DongMei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822741/
https://www.ncbi.nlm.nih.gov/pubmed/36618968
http://dx.doi.org/10.1155/2022/9010514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822741/
https://www.ncbi.nlm.nih.gov/pubmed/36618968
http://dx.doi.org/10.1155/2022/9010514

Ejemplares similares